Current Research Interests:

• General pulmonary & critical care
• Lung cancer
• Aerosol therapy
• COPD
• Asthma
• Mechanical ventilation
• Smoking cessation

Board Certification:

• Internal Medicine
• Pulmonary Medicine
• Critical Care Medicine

Society Memberships:

• Fellow
  • American College of Chest Physicians
    
  • American College of Physicians
    
  • National College of Chest Physicians (India)
    
  • Indian College of Physicians
    
  • American Association of Respiratory Care
• Member
  • American Thoracic Society
    
  • American Association of Respiratory Care
    
  • International Society for Aerosols in Medicine
    
  • European Respiratory Society
    
  • American Association for the Advancement of Science
    
  • National Academy of Medical Sciences (India)
    
  • Association of Physicians of India
    
  • American College of Physicians
    
  • Vice President, Missouri Thoracic Society, 2002-05
    
  • Appointed Member, ATS International Lung Health Committee, 2003-05
    
  • Invited Member, AZ Disease Control Research Commission Review Panel, 2005-09
  • Invited Member: ERS/ISAM Joint Task Force on New Inhalation
    Therapies, 2008-present

Editorial Board Member 

• Advances in Therapy
• CHEST
  
• Current Opinion in Pulmonary Medicine
  
• International Journal of Chronic Obstructive Pulmonary Disease (COPD)
  
• Journal of Aerosol Medicine
  
• Respiratory Care
  
• Sleep and Respiratory Neurobiology Section: Current Opinion in Pulmonary Medicine
  
• Update in Respiratory Care and Applied Technology

Current Grants:

• R. Dhand: PI
  Tolerance and Safety of Direct Targeted Aerosol Chemotherapy
  Joan’s Legacy (Joan Scarangello Foundation to Conquer Lung Cancer)
  Dates: November 2, 2006 – May 1, 2009
  Amount: $100,000.00

• R. Dhand: PI
  Genomic Analysis of Circulating Plasma DNA for Diagnosis of Lung Cancer
  Pilot and Collaborative Clinical and Translational Studies Grant
  MU Institute for Clinical and Translational Science
  Dates: 2009 – 2012
  Amount: $49,997.00
  Submitted: 3/6/09

Current Clinical Trials:

• Dhand R. PI. Sohal H Co-investigator. Novartis COPD: A 26-week treatment, multi-center, randomized double-blind placebo-controlled, adaptive, seamless, parallel-group study to assess the efficacy, safety and tolerability of two doses of Indacaterol in patients with COPD using blinded Formoterol and open label Tiotropium as active controls. Project ID 00017470. Amount: $238,139.00 Dates: 7/1-07 – 12/31/08.
• Dhand R. PI. Sohal H. Co-investigator. A 26-week extension to the 26-week treatment, multicenter, randomized, double-blind, double dummy, placebo-controlled, adaptive, seamless, pararallel-group study to assess the efficacy, safety, and tolerability of two doses of Indacterol in patients with chronic obstructive pulmonary disease using blinded Formoterol and open label Tiotropium as active controls. Protocol CQAB149B2335S. Amount: $17,149. (Awarded). Novartis Pharmaceuticals, Inc.

UHC Committees:

• Invited Member, International Search Committee for Nellie B. Smith Chair and Director, Division of Hematology and Oncology, 2006 - 2008
• Member, Leadership Committee, EMR System, 2002 - present
  
• Member, Research Council, Department of Internal Medicine, 2002 - present
  
• Chair, Task Force, Institutional Policy for Decannulation of Tracheostomies, University Health Care System, 2002-present
  
• Member, Subcommittee for Percutaneous Tracheostomy, University Health Care System, 2007 – present
  
• Member, Credentials Committee: Subcommittee for Percutaneous Tracheostomy, University Health Care System. 2007 – present
  
• Member, Promotion and Tenure Committee, Department of Internal Medicine, 2008 – present